Parliamentary panel seeks pharma and smartphone tariff exemptions in India-US trade pact
A parliamentary panel has recommended tariff exemptions for pharmaceuticals and smartphones in the proposed India-US bilateral trade agreement, calling for an early conclusion while protecting Indian interests amid uncertainty around US tariff policy.
A parliamentary panel recommended tariff exemptions for pharmaceuticals and smartphones in the proposed India-US bilateral trade agreement, urging an early conclusion while safeguarding Indian interests amid uncertainty over US tariffs.
Why this matters
No related recent signals are provided. The recommendation adds to accelerating retail-company activity by highlighting how trade-policy negotiations could affect India’s pharma and smartphone sectors.
Retail-company activity is accelerating, up +94,906% QoQ.
Also reported by
- The Hindu BusinessLine — Same time